IPP Bureau
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer
By IPP Bureau - November 21, 2025
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Merck’s WINREVAIR shows promise in phase 2 study for hard-to-treat pulmonary hypertension
By IPP Bureau - November 21, 2025
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
India’s Diabetes Crisis: Awareness and monitoring gaps threaten millions
By IPP Bureau - November 21, 2025
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
AbbVie’s EPKINLY gains FDA nod for relapsed follicular lymphoma, offering new hope for patients
By IPP Bureau - November 21, 2025
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
BPL Medical Technologies brings next-gen Korean ultrasound to India
By IPP Bureau - November 21, 2025
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
Healthium Medtech to invest Rs. 150 crore in new Sri City facility, create 400 jobs
By IPP Bureau - November 21, 2025
Merck’s two-drug HIV regimen hits phase 3 success
By IPP Bureau - November 21, 2025
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
Merck receives EU nod for first subcutaneous formulation, promising faster cancer treatment
By IPP Bureau - November 21, 2025
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
GSK and Fleming Initiative launch bold new fight against antimicrobial resistance
By IPP Bureau - November 21, 2025
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
GSK teams up with LTZ Therapeutics to launch next-generation cancer therapies
By IPP Bureau - November 21, 2025
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
Merck KGaA fires up new supercomputer to turbocharge scientific breakthroughs
By IPP Bureau - November 21, 2025
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
Alkem launches globally acclaimed De Simone Probiotic in India, expands GI portfolio
By IPP Bureau - November 21, 2025
The formulation is backed by over 80 clinical trials and 200 scientific publications
Mankind Pharma inks licencing pact with Actimed to bring cachexia treatments to South Asia
By IPP Bureau - November 21, 2025
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India
By IPP Bureau - November 21, 2025
The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
SOMA and Aura partner to advance innovation in on-press color correction
By IPP Bureau - November 21, 2025
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
